Sialadenosis epidemiology and demographics: Difference between revisions
No edit summary |
|||
Line 17: | Line 17: | ||
Men develop more stones than women, and the majority of cases occur in individuals between the ages of 30 and 60 years. Stones rarely occur in children. | Men develop more stones than women, and the majority of cases occur in individuals between the ages of 30 and 60 years. Stones rarely occur in children. | ||
Sialadenosis commonly affects individuals between the ages of 30 and 60 years. <ref name="pmid3318353">{{cite journal |vauthors=McKenna JP, Bostock DJ, McMenamin PG |title=Sialolithiasis |journal=Am Fam Physician |volume=36 |issue=5 |pages=119–25 |year=1987 |pmid=3318353 |doi= |url=}}</ref> | |||
Sialadenosis is rarely seen in children. | |||
Stones occur equally on the right and left sides | |||
===Incidence=== | ===Incidence=== |
Latest revision as of 14:41, 29 January 2018
Sialadenosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Sialadenosis epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Sialadenosis epidemiology and demographics |
Risk calculators and risk factors for Sialadenosis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Epidemiology and Demographics
The incidence of sialadenosis 1000 per 100,000 individuals worldwide in autopsies.[1]
In1991 to 1995, the incidence of symptomatic sialadenosis was estimated to be 2.7 to 5.9 cases per 100,000 individuals in England.[2]
Percent of stones in different glands:[3]
- Submandibular glands: 80 to 92 percent
- Parotid glands: 6 to 20 percent
- Sublingual and minor salivary glands: 1 to 2 percent
Men develop more stones than women, and the majority of cases occur in individuals between the ages of 30 and 60 years. Stones rarely occur in children. Sialadenosis commonly affects individuals between the ages of 30 and 60 years. [4]
Sialadenosis is rarely seen in children.
Stones occur equally on the right and left sides
Incidence
- The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
- In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
Prevalence
- The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
- In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
- The prevalence of [disease/malignancy] is estimated to be [number] cases annually.
Case-fatality rate/Mortality rate
- In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
- The case-fatality rate/mortality rate of [disease name] is approximately [number range].
Age
- Patients of all age groups may develop [disease name].
- The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
- [Disease name] commonly affects individuals younger than/older than [number of years] years of age.
- [Chronic disease name] is usually first diagnosed among [age group].
- [Acute disease name] commonly affects [age group].
Race
- There is no racial predilection to [disease name].
- [Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].
Gender
- [Disease name] affects men and women equally.
- [Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.
Region
- The majority of [disease name] cases are reported in [geographical region].
- [Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].
Developed Countries
Developing Countries
References
- ↑ Williams MF (1999). "Sialolithiasis". Otolaryngol. Clin. North Am. 32 (5): 819–34. PMID 10477789.
- ↑ Escudier MP, McGurk M (1999). "Symptomatic sialoadenitis and sialolithiasis in the English population, an estimate of the cost of hospital treatment". Br Dent J. 186 (9): 463–6. PMID 10365495.
- ↑ Mandel L (2014). "Salivary gland disorders". Med. Clin. North Am. 98 (6): 1407–49. doi:10.1016/j.mcna.2014.08.008. PMID 25443682.
- ↑ McKenna JP, Bostock DJ, McMenamin PG (1987). "Sialolithiasis". Am Fam Physician. 36 (5): 119–25. PMID 3318353.